Key result
OPUS digoxin assay avoids DLIS interference compared to ~40% incidence with the TDxII assay.
Why the study?
How do the Abbott TDxII, Baxter Stratus, and Behring OPUS digoxin assays compare in accuracy, precision, and susceptibility to digoxin-like immunoreactive substances?
Observational
How do the Abbott TDxII, Baxter Stratus, and Behring OPUS digoxin assays compare in accuracy, precision, and susceptibility to digoxin-like immunoreactive substances?
The Behring OPUS assay and ultrafiltered TDxII are preferred for measuring digoxin levels in patients with potential digoxin-like immunoreactive substances or those treated with Digibind.
Answers are grounded in this paper and cite their sources.
May warrant assay-specific caution in digoxin TDM for DLIS-prone patients; leaves open prospective outcome validation.
Three automated immunoassays for digoxin in serum were evaluated--Abbott TDxII, Baxter Stratus, and Behring OPUS. The accuracy and precision of the assays were assessed by weighed-in controls and an external quality control program. Coefficients of variation of all methods in serum were < or = 10% at weighed-in concentrations of digoxin of 1 and 2.5 micrograms/L. Accuracy relative to weighed-in concentrations of 1 and 2.5 micrograms/L ranged from 98 to 126% for all methods. Comparative results from patient samples showed little difference between the TDxII and Stratus and a greater difference observed between the TDxII and OPUS assays. The detection of digoxin-free samples containing digoxin-like immunoreactive substances (DLIS) in neonatal cord blood, pregnant patients, and liver and renal recipients by each assay was then assessed. The TDxII exhibited the highest incidence of DLIS. This is evident in neonatal cord blood in which 40.4% of samples tested positive. In comparison, the extent of DLIS detected by Stratus was less and OPUS exhibited no DLIS in any of the groups studied. A case study of a patient treated with anti-digoxin Fab fragments (Digibind) also was included for analysis by each method. Fourteen hours after Digibind administration, the TDxII registered a digoxin concentration of 49.5 micrograms/L compared with 3.73, 1.80, and 2.49 micrograms/L for Stratus, OPUS, and ultrafiltered TDxII methods, respectively. The results indicate that to determine the concentration of digoxin after the administration of Digiband, the OPUS or fluorescence polarization immunoassay (FPIA)-ultrafiltered samples by TDxII are the assays of choice.
No takes yet. Share an insight, caveat, or question.
Dodds et al. (1995) conducted an observational in Digoxin monitoring. Abbott TDxII, Baxter Stratus, and Behring OPUS assays was evaluated on Accuracy, precision, and detection of digoxin-like immunoreactive substances (DLIS). The OPUS assay exhibited no digoxin-like immunoreactive substances interference, whereas the TDxII assay had the highest incidence.
Synapse has enriched 10 related papers. Consider them for comparative context: